PenderFund Capital Management’s Verona Pharma VRNA Stock Holding History

PenderFund Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,900	Closed	-$416K	–	262
2025 Q3	$416K	Buy	+3,900	New	+$407K	0.07%	67

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

PenderFund Capital Management's VRNA Position: Q4 2025 in Review

PenderFund Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 3,900 shares — an estimated $416K sold.

PenderFund Capital Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $416K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

PenderFund Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
PenderFund Capital Management sold 3,900 Verona Pharma shares in Q4 2025, an estimated $416K.
PenderFund Capital Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
PenderFund Capital Management's Verona Pharma position peaked at $416K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on PenderFund Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.